Skip to content
Search

Latest Stories

Pharmacy staff encouraged to take up British Oncology Pharmacy Association’s cancer training course

To diagnose cancer early, patient-facing staff in the pharmacies have been encouraged to complete at least one module of a training course developed by the British Oncology Pharmacy Association’s (BOPA).

The 'Let’s Communicate Cancer' training has now been added to the Health Education England (HEE)'s e-learning for healthcare website that is aimed at all members of the pharmacy team and consists of four modules: Early diagnosis and prevention; What is cancer?; Treatment of cancer; and Supporting your patients with cancer.


Last week, NHS England and NHS Improvement announced that they are planning on piloting a direct referral service for patients who present at pharmacies with certain symptoms, to allow these patients to be sent for scans and other checks as part of a new drive to diagnose cancer early.

Commenting on the release of the training, PSNC director of NHS Services Alastair Buxton said: “Cpovid-19 has significantly impacted diagnosis rates of cancer with Macmillan estimating that around 50,000 patients have missed a cancer diagnosis during the pandemic.

"Pharmacy teams have a key role to play in the early detection of cancer, recognising red flag symptoms, which may indicate cancer, and referring these patients to their GPs.

"Patient-facing staff, who provide advice on medicines or healthcare are therefore encouraged to complete at least module one of the above training, to refresh their knowledge on recognising red flag symptoms and how to refer patients presenting with these symptoms.”

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less